1 Market Overview
1.1 Kidney (Renal) Fibrosis Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Kidney (Renal) Fibrosis Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Angiotensin Converting enzyme (ACE) Inhibitors
1.2.3 Pirfenidone
1.2.4 Renin Inhibitors
1.2.5 Angiotensin II Receptor Blockers (ARBs)
1.2.6 Vasopeptidase Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Kidney (Renal) Fibrosis Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.4 Global Kidney (Renal) Fibrosis Market Size & Forecast
1.4.1 Global Kidney (Renal) Fibrosis Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Kidney (Renal) Fibrosis Sales in Volume (2017-2028)
1.4.3 Global Kidney (Renal) Fibrosis Price (2017-2028)
1.5 Global Kidney (Renal) Fibrosis Production Capacity Analysis
1.5.1 Global Kidney (Renal) Fibrosis Total Production Capacity (2017-2028)
1.5.2 Global Kidney (Renal) Fibrosis Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Kidney (Renal) Fibrosis Market Drivers
1.6.2 Kidney (Renal) Fibrosis Market Restraints
1.6.3 Kidney (Renal) Fibrosis Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Kidney (Renal) Fibrosis Product and Services
2.1.4 Merck Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Kidney (Renal) Fibrosis Product and Services
2.2.4 Pfizer Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Kidney (Renal) Fibrosis Product and Services
2.3.4 Roche Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 InterMune
2.4.1 InterMune Details
2.4.2 InterMune Major Business
2.4.3 InterMune Kidney (Renal) Fibrosis Product and Services
2.4.4 InterMune Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Galectin Therapeutics
2.5.1 Galectin Therapeutics Details
2.5.2 Galectin Therapeutics Major Business
2.5.3 Galectin Therapeutics Kidney (Renal) Fibrosis Product and Services
2.5.4 Galectin Therapeutics Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 La Jolla Pharmaceutical Company
2.6.1 La Jolla Pharmaceutical Company Details
2.6.2 La Jolla Pharmaceutical Company Major Business
2.6.3 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Product and Services
2.6.4 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 ProMetic Life-Sciences Inc.
2.7.1 ProMetic Life-Sciences Inc. Details
2.7.2 ProMetic Life-Sciences Inc. Major Business
2.7.3 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Product and Services
2.7.4 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 BioLine Rx Ltd
2.8.1 BioLine Rx Ltd Details
2.8.2 BioLine Rx Ltd Major Business
2.8.3 BioLine Rx Ltd Kidney (Renal) Fibrosis Product and Services
2.8.4 BioLine Rx Ltd Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Genzyme Corporation
2.9.1 Genzyme Corporation Details
2.9.2 Genzyme Corporation Major Business
2.9.3 Genzyme Corporation Kidney (Renal) Fibrosis Product and Services
2.9.4 Genzyme Corporation Kidney (Renal) Fibrosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Kidney (Renal) Fibrosis Breakdown Data by Manufacturer
3.1 Global Kidney (Renal) Fibrosis Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Kidney (Renal) Fibrosis Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Kidney (Renal) Fibrosis
3.4 Market Concentration Rate
3.4.1 Top 3 Kidney (Renal) Fibrosis Manufacturer Market Share in 2021
3.4.2 Top 6 Kidney (Renal) Fibrosis Manufacturer Market Share in 2021
3.5 Global Kidney (Renal) Fibrosis Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Kidney (Renal) Fibrosis Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Kidney (Renal) Fibrosis Market Size by Region
4.1.1 Global Kidney (Renal) Fibrosis Sales in Volume by Region (2017-2028)
4.1.2 Global Kidney (Renal) Fibrosis Revenue by Region (2017-2028)
4.2 North America Kidney (Renal) Fibrosis Revenue (2017-2028)
4.3 Europe Kidney (Renal) Fibrosis Revenue (2017-2028)
4.4 Asia-Pacific Kidney (Renal) Fibrosis Revenue (2017-2028)
4.5 South America Kidney (Renal) Fibrosis Revenue (2017-2028)
4.6 Middle East and Africa Kidney (Renal) Fibrosis Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Kidney (Renal) Fibrosis Sales in Volume by Type (2017-2028)
5.2 Global Kidney (Renal) Fibrosis Revenue by Type (2017-2028)
5.3 Global Kidney (Renal) Fibrosis Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Kidney (Renal) Fibrosis Sales in Volume by Application (2017-2028)
6.2 Global Kidney (Renal) Fibrosis Revenue by Application (2017-2028)
6.3 Global Kidney (Renal) Fibrosis Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Kidney (Renal) Fibrosis Sales by Type (2017-2028)
7.2 North America Kidney (Renal) Fibrosis Sales by Application (2017-2028)
7.3 North America Kidney (Renal) Fibrosis Market Size by Country
7.3.1 North America Kidney (Renal) Fibrosis Sales in Volume by Country (2017-2028)
7.3.2 North America Kidney (Renal) Fibrosis Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Kidney (Renal) Fibrosis Sales by Type (2017-2028)
8.2 Europe Kidney (Renal) Fibrosis Sales by Application (2017-2028)
8.3 Europe Kidney (Renal) Fibrosis Market Size by Country
8.3.1 Europe Kidney (Renal) Fibrosis Sales in Volume by Country (2017-2028)
8.3.2 Europe Kidney (Renal) Fibrosis Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Kidney (Renal) Fibrosis Sales by Type (2017-2028)
9.2 Asia-Pacific Kidney (Renal) Fibrosis Sales by Application (2017-2028)
9.3 Asia-Pacific Kidney (Renal) Fibrosis Market Size by Region
9.3.1 Asia-Pacific Kidney (Renal) Fibrosis Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Kidney (Renal) Fibrosis Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Kidney (Renal) Fibrosis Sales by Type (2017-2028)
10.2 South America Kidney (Renal) Fibrosis Sales by Application (2017-2028)
10.3 South America Kidney (Renal) Fibrosis Market Size by Country
10.3.1 South America Kidney (Renal) Fibrosis Sales in Volume by Country (2017-2028)
10.3.2 South America Kidney (Renal) Fibrosis Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Kidney (Renal) Fibrosis Sales by Type (2017-2028)
11.2 Middle East & Africa Kidney (Renal) Fibrosis Sales by Application (2017-2028)
11.3 Middle East & Africa Kidney (Renal) Fibrosis Market Size by Country
11.3.1 Middle East & Africa Kidney (Renal) Fibrosis Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Kidney (Renal) Fibrosis Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Kidney (Renal) Fibrosis and Key Manufacturers
12.2 Manufacturing Costs Percentage of Kidney (Renal) Fibrosis
12.3 Kidney (Renal) Fibrosis Production Process
12.4 Kidney (Renal) Fibrosis Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Kidney (Renal) Fibrosis Typical Distributors
13.3 Kidney (Renal) Fibrosis Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
世界の腎臓（腎）線維症市場2022年：市場規模予測（～2028年） |
| 【英語タイトル】Global Kidney (Renal) Fibrosis Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 | |
 | ・商品コード：GIR22DC3844 ・発行会社（調査会社）：GlobalInfoResearch ・発行日：2023年1月 ・ページ数：97 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（注文後2-3日） ・調査対象地域：グローバル ・産業分野：医薬品 |
| Single User（1名様閲覧用） | USD3,480 ⇒換算￥528,960 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD5,220 ⇒換算￥793,440 | 見積依頼/購入/質問フォーム |
| Corporate User（同一法人内共有可） | USD6,960 ⇒換算￥1,057,920 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 腎臓（腎）線維症市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の腎臓（腎）線維症の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 腎臓（腎）線維症市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・アンジオテンシン変換酵素（ACE）阻害剤、ピルフェニドン、レニン阻害剤、アンジオテンシンII受容体拮抗薬（ARB）、バソペプチダーゼ阻害剤 用途別セグメントは次のように区分されます。 ・研究センター、病院、診療所 世界の腎臓（腎）線維症市場の主要な市場プレーヤーは以下のとおりです。 ・Merck、Pfizer、Roche、InterMune、Galectin Therapeutics、La Jolla Pharmaceutical Company、ProMetic Life-Sciences Inc.、BioLine Rx Ltd、Genzyme Corporation 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、腎臓（腎）線維症製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な腎臓（腎）線維症メーカーの企業概要、2019年～2022年までの腎臓（腎）線維症の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な腎臓（腎）線維症メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別腎臓（腎）線維症の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの腎臓（腎）線維症の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での腎臓（腎）線維症市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および腎臓（腎）線維症の産業チェーンを掲載しています。 ・第13、14、15章では、腎臓（腎）線維症の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 腎臓（腎）線維症の概要 - 種類別分析（2017年vs2021年vs2028年）：アンジオテンシン変換酵素（ACE）阻害剤、ピルフェニドン、レニン阻害剤、アンジオテンシンII受容体拮抗薬（ARB）、バソペプチダーゼ阻害剤 - 用途別分析（2017年vs2021年vs2028年）：研究センター、病院、診療所 - 世界の腎臓（腎）線維症市場規模・予測 - 世界の腎臓（腎）線維症生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Merck、Pfizer、Roche、InterMune、Galectin Therapeutics、La Jolla Pharmaceutical Company、ProMetic Life-Sciences Inc.、BioLine Rx Ltd、Genzyme Corporation ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：アンジオテンシン変換酵素（ACE）阻害剤、ピルフェニドン、レニン阻害剤、アンジオテンシンII受容体拮抗薬（ARB）、バソペプチダーゼ阻害剤 ・用途別分析2017年-2028年：研究センター、病院、診療所 ・腎臓（腎）線維症の北米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・腎臓（腎）線維症のヨーロッパ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・腎臓（腎）線維症のアジア市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・腎臓（腎）線維症の南米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・腎臓（腎）線維症の中東・アフリカ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Kidney (Renal) Fibrosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Kidney (Renal) Fibrosis market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Research Center accounting for % of the Kidney (Renal) Fibrosis global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Angiotensin Converting enzyme (ACE) Inhibitors segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Kidney (Renal) Fibrosis include Merck, Pfizer, Roche, InterMune, and Galectin Therapeutics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Kidney (Renal) Fibrosis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Angiotensin Converting enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasopeptidase Inhibitors
Market segment by Application can be divided into
Research Center
Hospital
Clinic
The key market players for global Kidney (Renal) Fibrosis market are listed below:
Merck
Pfizer
Roche
InterMune
Galectin Therapeutics
La Jolla Pharmaceutical Company
ProMetic Life-Sciences Inc.
BioLine Rx Ltd
Genzyme Corporation
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Kidney (Renal) Fibrosis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Kidney (Renal) Fibrosis, with price, sales, revenue and global market share of Kidney (Renal) Fibrosis from 2019 to 2022.
Chapter 3, the Kidney (Renal) Fibrosis competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Kidney (Renal) Fibrosis breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Kidney (Renal) Fibrosis market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Kidney (Renal) Fibrosis.
Chapter 13, 14, and 15, to describe Kidney (Renal) Fibrosis sales channel, distributors, customers, research findings and conclusion, appendix and data source.
❖ レポートの目次 ❖
| ★調査レポート[世界の腎臓（腎）線維症市場2022年：市場規模予測（～2028年）] (コード：GIR22DC3844)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の腎臓（腎）線維症市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせ |
